Abionyx Pharma (XPAR:ABNX) Change In Inventory : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Abionyx Pharma Change In Inventory?

Abionyx Pharma's change in inventory for the quarter that ended in Dec. 2023 was €0.00 Mil. It means Abionyx Pharma's inventory stayed the same from Jun. 2023 to Dec. 2023 .

Abionyx Pharma's change in inventory for the fiscal year that ended in Dec. 2023 was €-0.08 Mil. It means Abionyx Pharma's inventory increased by €0.08 Mil from Dec. 2022 to Dec. 2023 .

Abionyx Pharma's Total Inventories for the quarter that ended in Dec. 2023 was €0.22 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Abionyx Pharma's Days Inventory for the quarter that ended in Dec. 2023 was 18.41.

Inventory Turnover measures how fast the company turns over its inventory within a year. Abionyx Pharma's Inventory Turnover for the quarter that ended in Dec. 2023 was 9.91.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Abionyx Pharma's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.08.

Abionyx Pharma Change In Inventory Historical Data

The historical data trend for Abionyx Pharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abionyx Pharma Change In Inventory Chart

Abionyx Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

0.01

0.03

-0.08

Abionyx Pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Abionyx Pharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Abionyx Pharma (XPAR:ABNX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Abionyx Pharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.19	/	1.883	*	365 / 2
	=	18.41

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Abionyx Pharma's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.883	/	0.19
	=	9.91

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Abionyx Pharma's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.19	/	2.512
	=	0.08

Abionyx Pharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of Abionyx Pharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Abionyx Pharma (XPAR:ABNX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abionyx Pharma (XPAR:ABNX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

609:Germany

Address

33-43 Avenue Georges Pompidou-Bat D2, Balma, FRA, 31130

Website

https://www.abionyx.com

Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.

Abionyx Pharma (XPAR:ABNX) Headlines

No Headlines